Open Access<p>Galectin-3 as a prognostic biomarker for diabetic nephropathy</p>
Author(s) -
Hossam Hodeib,
Maha M Hagras,
Dina Abdelhai,
Mona Watany,
Amal Selim,
Mohamed A Tawfik,
Mohamed A Elsebaey,
Samah A Elshweikh
Publication year - 2019
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s194410
Subject(s) - biomarker , galectin 3 , galectin , diabetic nephropathy , medicine , oncology , cancer research , chemistry , immunology , kidney , biochemistry
Diabetic nephropathy (DN) represents one of the main causes of end-stage renal disease in type 2 diabetes mellitus (DM) patients. Galectin-3 has been implicated in pathogenesis of many pathological conditions. To date, there are limited data regarding the relationship between galectin-3 and DN.